Frontlight ResearchEarly access
Trial site
IRCCS Oncologico Istituto Tumori "Giovanni Paolo II"
- 1running trial
- 1closed trial
The trials here
What the 2 trials at this site are about, from their registry records.
- Conditions
- Lung cancer1 trial
- Metastatic breast cancer1 trial
- Phase
- Phase 22 trials
- Status
- Active, not recruiting1 trial
- Withdrawn1 trial
- Lead sponsor
- Dompé Farmaceutici S.p.A1 trial
- Fondazione Ricerca Traslazionale1 trial
Running trials
Active, not recruiting
Atezolizumab Versus Atezolizumab Plus Bevacizumab as First Line in NSCLC Patients (BEAT)
Closed trials
Site data: ClinicalTrials.govUpdated 12 Nov 2026